Softgel Capsules Market

Softgel Capsules Market Size

The global softgel capsules market size was estimated at USD 9.3 billion in 2024. The market is expected to grow from USD 9.8 billion in 2025 to USD 18.4 billion in 2034, at a CAGR of 7.2%. The growing consumption of nutraceuticals such as vitamins, supplements containing omega-3 fatty acids, and herbal medicine due to their convenience in consumption and better absorption than regular medicines contribute to market growth.

For instance, 77% of Americans reported consuming dietary supplements in 2023, with softgel-based supplements seeing the highest growth, according to a report by the Council for Responsible Nutrition. Also, the increasing application of softgel capsules in a variety of therapeutic areas such as oncology, pain management, and dermatology, increases the adoption rate of the softgel capsules-based formulation.

Continuous technological advancements in the softgel capsules manufacturing field are one of the major factors accelerating the softgel capsules market growth. Growing adoption of novel products such as hydroxypropyl methylcellulose (HPMC), potato starch, pullulan, pectin and others in softgel manufacturing will boost the industry growth potential. Also, increased demand for immune system boosters during pandemic has boosted the demand for health & dietary supplements. Therefore, amid the pandemic, high demand for vitamin softgel capsules has strengthened revenue size. Moreover, the growing population trend toward a healthy lifestyle has stimulated demand for diet supplements during the pandemic and helped the industry to grow substantially in past years.

Soft gel, also known as soft gelatin capsules, are solid forms of dosages consisting of one-piece solid capsules in which the outer shell is filled with a wide variety of compounds such as liquid, semi-solid, gel or paste. These capsules have several advantages such as easy to swallow, taste masking, unit dose delivery and are tamper-proof. Moreover, softgel capsules are widely used for drugs with poor biopharmaceutical properties, such as low aqueous solubility, permeability to deliver through oral route of administration.

Softgel Capsules Market Trends

• Innovations in capsule production machinery such as automated filling and selling technologies allow for cost effective production of softgel, creating a gradual shift towards more profitable needs for pharmaceuticals and nutraceutical companies.
  
• There is an escalating preference towards natural and organic dietary supplements, especially in the form of softgel capsules. This change is likely to spur the demand for organic plant-based softgel capsules. For example, in October 2023, IVC Nutrition Corporation claimed that they were going to sell patented vegan softgel capsules for nutraceuticals, which focuses on the increasing demand for supplemental vegan alternatives to gelatin capsules.
  
• Also, the rising global elderly population increases the demand for softgel capsules for easy to swallow medications which aids the growth of the market. As per the report published by the World Health Organization, it has been estimated that the share of the population above 60 years was 1 billion in 2020 and are estimated to reach 1.4 billion by 2030.
  
• This means that 1 in 6 people in the world will be above 60 years of age by the year 2030. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). This rapid increase in the global geriatric population is more susceptible to chronic disease like arthritis, cardiovascular disease, and others, thereby driving the demand for softgel capsules formulation.
  
• Furthermore, the growing trend of wellness in emerging countries such as Brazil, China and India coupled with the increase in the number of product approvals in developing countries, increase the adoption of softgel capsules. ICPA Health Products created Mucofibro soft gel capsules in August 2023 to assist in the healing of oral lesions and precancerous conditions.
  
• The increasing demand of vegan capsules is revolutionizing the entire softgel capsule market, resulting in better, more effective, and patient-centered solutions which facilitates the growth of the market.
  

Softgel Capsules Market Analysis

Based on type, the global market is divided into gelatin-based and vegetarian capsules. The gelatin-based segment dominated the market and was valued at USD 8.4 billion in 2024, growing from USD 7.9 billion in 2023 and USD 7.4 billion in 2022.

• Gelatin-based softgel offer several benefits over tablets and capsules, including better bioavailability, ease of swallowing, faster onset of action, and protection of sensitive ingredients from degradation due to light, air, or moisture.
  
• Also, the rise in encapsulation technologies with the introduction of plant-based gelatin alternatives such as tapioca, and seaweed extracts, caters for the growing demand for vegan consumer base, thereby adjuvating market growth.
  
• Furthermore, the increasing demand for omega 3 supplements delivered in gelatin-based softgel formulation saw a significant increase of 7.4% in global demand in 2023.  
  
• The increasing preference of pharmaceutical and nutraceutical manufacturers towards gelatin-based capsules with rising the number of product approvals by regulatory bodies stimulates the market growth over the coming years. In December 2023, Amneal Pharmaceuticals, and Strides Pharma Science Limited announced the addition of Icosapent ethyl acid soft gel capsules, a product referencing VASCEPA.
  
• Thus, the growing favorable regulatory environment for the introduction of new products in the market boost the growth of the market.  
  

Based on the application, the global softgel capsules market is categorized into health and dietary supplements, prescription medicine and other applications. The health and dietary supplements is further sub-segmented into vitamins, enzymes, omega, minerals and other health and dietary supplements. The health and dietary supplements segment accounted for the highest market share of 65.4% in 2024 and is anticipated to witness growth at a CAGR of 7.5% during the analysis period.

• The major factor contributing to segmental growth includes the rising adoption of several dietary supplements to improve and maintain a healthy lifestyle. Growing demand for minerals and vitamins to boost immunity coupled with rising health-consciousness among population across the globe will propel the demand for dietary supplements.
  
• The rising trend toward preventative healthcare is encouraging consumers to adopt supplements as part of their daily routine to prevent chronic conditions such as heart disease, diabetes, and osteoporosis.
  
• Also, the increase in the cost of healthcare is inducing more attention to the prevention of using supplements to reduce long-term costs, thereby further drives the market.
  
• Moreover, advancement in softgel technology has improved the production process, making softgel capsules more cost-effective and allowing for the inclusion of a wider range of ingredients, including oils, powders, and liquids.
  
• This has expanded the range of supplements available in softgel form, further driving their demand that boosts market growth.
  

Based on the indication, the global softgel capsules market is categorized into humans and animals. The humans segment dominated the market with USD 8.4 billion in 2024 and is anticipated to reach USD 16.4 billion by 2034.

• The growing aging population, especially in developed countries, increases the demand for softgel capsules based formulation owing to their ease of swallowing and better compliance with daily medication or supplementation routines.
  
• Also, the growing popularity of vitamins, minerals, and herbal supplements has led to an increase in the demand for softgel capsules in the human market.
  
• Softgel capsules are increasingly valued in the pharmaceutical industry for their aesthetic appeal, which has led to greater adoption among consumers who value the ease and elegance of softgel formulations, thereby contributing to market growth.
  
• Additionally, the regulatory authorities such as U.S. FDA, EMA and PMDA approved several softgel-based formulations for various health conditions such as cardiovascular disease, cancer and vitamin deficiencies. For example, in August 2024, Concept Matrix Solutions announced that it has received patent issuance from the U.S. Patent Office (USPTO) for its oral soft gel capsule containing psychedelic compound.
  
• This patent marks a significant milestone in the company’s efforts to develop more effective treatments for mental health disorders and chronic pain conditions.
  

Based on the end use, the global softgel capsules market is categorized into pharmaceutical companies, nutraceutical companies, veterinary industry and other end users. The nutraceutical companies segment dominated the market in 2024 and is anticipated to reach USD 8.4 billion by 2034.

• The growing health-consciousness among people will stimulate the demand for nutrition and dietary supplements. Also, the rise of e-commerce platforms and direct-to-consumer (DTC) models has expanded the reach of nutritional softgel supplements, thereby contributing to market growth.
  
• Regulatory agencies in various regions are supporting the use of nutraceuticals for health benefits, which has led to the development of new products in the softgel format. For example, the European Food Safety Authority (EFSA) has approved various health claims for supplements, encouraging their use.
  
• Furthermore, improved availability and accessibility to medicines even in remote areas will support segmental growth over the projected timeframe.
  

In 2024, the U.S. softgel capsule held a significant position in the North America softgel capsules market and was valued at USD 3.6 billion.

• The increasing trend toward self-medication in the U.S., with consumers increasingly turning to over the counter (OTC) drugs and supplements to manage health conditions independently, increases the demand for softgel capsules.
  
• The growth of the nutraceuticals and supplements market and the development of the dry form softgel capsule market is aided due to the FDA's regulatory supportive stance, as well as the increased funding in research and development (R&D) activities. This includes the approvals of new formulations of drugs and dietary supplements in softgel capsule forms.
  
• For example, in August 2023, Ipsen announced approval by the U.S. Food and Drug Administration (FDA) of Sohonos (palovarotene) capsules as a retinoid indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP).
  
• Moreover, the rising popularity of cannabis and CBD products enhances the demand for cannabidiol (CBD) infused softgel capsules, which further increases the growth of the market.
  

Germany shows strong growth potential in the Europe softgel capsules market.

• There is a growing focus on health and wellness among Germans which increase the consumption of nutraceuticals and dietary supplements. Vitamins, minerals, and other dietary supplements softgel capsules are easy to swallow and are a popular option.
  
• As reported by Statista, in 2023, nearly 14 million people in Germany consumed vitamins and other food supplements once daily, while approximately 5.31 million took the supplements two to three times a week.
  
• Further, Germany is known to have many multinational companies within the softgel industry. Market leaders, such as Capsugel (Lonza Group) and Catalent from the USA, are well established in Germany which helped further develop the market.
  
• For instance, one of the largest developers and manufacturers of softgel in Europe is Eberbach. Eberbach based pharmaceutical company has a capacity of 12.8 billion softgel capsules per year.
  

China softgel capsules market shows strong growth potential in Asia Pacific market over the next few years.

• China has seen a significant increase in the demand for nutraceuticals and dietary supplements, driven by rising awareness about health and wellness. Softgel capsules are preferred due to their ease of consumption, fast absorption, and ability to encapsulate a wide range of ingredients such as vitamins, minerals, and herbal supplements.
  
• Also, China’s aging population is a critical factor in the growth of the market. The aging population creates a demand for health supplements, especially for joint health, bone health, and anti-aging products, all of which are commonly formulated in softgel capsules.
  
• For instance, according to the World Bank, China’s elderly population (over 65 years) accounted for about 12.5% of the total population in 2023, and this figure is expected to rise in the coming timeframe.
  
• Furthermore, the government of China has been supportive to pharmaceutical industry by ensuring improved regulatory frameworks for new drug development and manufacturing, thereby contributing to market growth.
  

Brazil's softgel capsules sector is projected to witness significant growth in the Latin America softgel capsules market.

• Chronic diseases such as diabetes, heart conditions, and obesity have increased in Brazil, which increases the demand for medications in various forms including softgel capsules.
  
• Brazil’s National Health Surveillance Agency provides oversight in the margin of safety and control over pharmaceutical and health products, establishing stringent regulations that guarantee the safety of consumers and the quality of the products being marketed.
  
• This is important in maintaining market expansion, particularly for soft gel capsules that are viewed as premium, highly sought after, and innovative products.
  

Softgel Capsules Market Share

The top 5 players such as Delpharm Evreux, Catalent, Capsugel, Patheon and Nutramax Laboratories accounts for between 30% - 40% of the market share. These players adopted various strategies such as acquisition, business expansion, research and development activities and novel product launches to consolidate their market presence. For instance, as per the March 2021 data Delpharm Evreux collaborated with Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, has successfully scaled and qualified a new softgel capsule with a plant-based shell. Key players are engaging in strategic initiatives such as collaboration, product launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting multi-pronged approaches to address the rising demand for softgel capsules.

Further, the market is highly fragmented with large number of small players operating in the market. This creates an opportunity for market consolidation. Hence, leading players are constantly adopting key strategies for the growth of the market.

Collaborations with research institutions and significant investments in R&D promote the creation of novel softgel products, addressing unmet consumer needs. Efforts to enhance affordability, accessibility, and sustainability also play a crucial role in capturing market share in underserved regions, enabling companies to strengthen their global presence.

Softgel Capsules Market Companies

These companies are leveraging their robust R&D capabilities to develop innovative formulations, optimize production processes, and improve product accessibility. At the same time, emerging pharmaceutical and biotech firms are introducing novel approaches and targeting new delivery mechanisms, contributing to the market's dynamism and fostering rapid advancements. Prominent players operating in the softgel capsules industry are as mentioned below:

• Aenova Group
• Capsugel (Lonza)
• Captek Softgel International
• Catalent
• Curtis Health Caps
• Delpharm Evreux
• Estrellus
• Eurocaps
• Fuji Capsules
• Guangdong Yichao Biological
• Nutramax Laboratories
• Patheon
• Procaps Group
• Sirio Pharma 
  

The growth of the market is driven by proactive strategies from leading pharmaceutical companies and biotech firms. Major players, such as Aenova Group and Catalent, are actively focused on meeting consumer demands and overcoming key industry challenges. The key players of the market, such as Procaps Groups, focuses on collaboration, agreement, mergers and acquisitions to gain a competitive edge in the market.

For instance, in December 2023, Procaps Group, an international healthcare and pharmaceutical services company, and Genomma Lab Internacional, a pharmaceutical and personal care company in Latin America, entered into a strategic agreement to develop, manufacture and market five Softgel products within Latin America. Through this partnership, Procaps will manufacture and Genomma will market and distribute the products. Companies are also focusing on the expansion of their existing business by introducing more softgel capsules formulations in the market.

Softgel Capsules Industry News

• In December 2023, Amneal Pharmaceuticals, and Strides Pharma Science (“Strides”) announced the addition of Icosapent ethyl acid soft gel capsules, a product referencing VASCEPA. The product has been in-licensed from Strides and will be commercialized by Amneal starting in the fourth quarter of 2023. This helped the company expand its product range.
  
• In October 2022, Aenova Group and Microcaps an innovative, Swiss start-up company entering a strategic partnership with the aim of accelerating and improving the development and production of pharmaceuticals, food supplements and numerous other products including softgel capsules. This strategy is expected to enhance the company’s outreach to untapped economies.
  
• In September 2021 Aenova Group, has already been producing vegan softgel capsules based on seaweed extract for some time. Now the VegaGels on a purely vegetable basis are being expanded to include a chewable variant. This approval aimed to broaden the treatment availability, complementing existing products.
  

The softgel capsules market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Gelatin based
• Vegetarian capsules

Market, By Application

• Health and dietary supplements
  • Vitamins
  • Enzymes
  • Omega
  • Minerals
  • Other health and dietary supplements
• Prescription medicine
  • Antibiotics and antivirals
  • Anti-inflammatory drugs
  • Cough and cold drugs
  • Other prescription medicines
• Other applications

Market, By Indication

• Humans
• Animals

Market, By End Use

• Pharmaceutical companies
• Nutraceutical companies
• Veterinary industry
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE